Genomatix Software GmbH today announced that it has achieved GeneChip-compatible TM status for several products with the Affymetrix Inc. (Nasdaq: AFFX) GeneChip® microarray platform and that it has ...

Microarray Market Is Growing as Applications for Diagnostics and Research Are Realized Although DNA microarrays are just beginning to be investigated for diagnostics, they are becoming key tools for ...

Affymetrix Showcases Third-Party Microarray Analysis Software Like it or not, biologists have to deal increasingly in informatics as their experiments generate ever larger and more complex data sets.

The widely-used Affymetrix Whole-Transcript Gene 1.0 ST (sense target) microarray platform, normally used to assay gene expression, can also be utilized to interrogate exon-specific splicing. Research ...

Affymetrix Inc. has announced the publication of the MicroArray Quality Control (MAQC) study, a collaborative effort led by the FDA that included 137 scientists from private and public sector ...

When scientists finished mapping the human genome, they thought their work was done. However, they have since found out that there is such a thing as too much information. There are only a little more ...

Microarray giant Affymetrix has updated two of its more popular expression sets. With the release of the GeneChip ® Mouse Expression Set 430 and Rat Expression Set 230, the company now provides "the ...

Genomatix Software GmbH has announced that it has achieved GeneChip-compatible™ status for several products with the Affymetrix Inc. GeneChip ® microarray platform and that it has joined Affymetrix ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix (Nasdaq:AFFX) and Ariosa Diagnostics, Inc. today announced the signing of a multi-year supply agreement covering Affymetrix arrays and instruments to ...

Relationship of pro-angiogenic factor Cyr61to colorectal cancer development and prognosis. Background: Microarrays are widely used to study gene expression patterns in cancer. In colorectal cancer, it ...